Social media’s potential as a tool to raise awareness in healthcare issues has become a ‘hot’ topic for pharmaceutical communications over the past 12 months; the abundance of ‘patient-to-physician’ and ‘physician-to-physician’ websites means that information on healthcare issues is now more accessible than ever before. But how can the pharmaceutical industry address the matter?
Through the use of case studies and interactive presentations, this Masterclass will provide delegates with a comprehensive understanding of where we have come from, where we are and where we are headed as far as the pharmaceutical industry’s engagement in digital communication is concerned.
Delegates can expect to consider how their organisation’s use of social media can be aligned with the way end-users interact with healthcare conversations online and how their choice of tools, channels and messages needs to be tailored to particular target demographics.
Benefits of attending:
The aim of SMi is Linking Business with Information through the delivery of high quality business to business information services. Our overriding advantage is our flexibility and ability to respond quickly to the requirements and needs of all our customers, ensuring that all SMi products are highly relevant, innovative and timely.
The SMi Group is a world leader in business to business information. Within the past year thousands of senior executives from blue chip companies benefited from SMi's highly targeted conferences, workshops and masterclasses.
As a market research based organisation, SMi takes pride in the quality of its programmes and documentation, ensuring that they are brought to the attention of the key decision makers in each industry sector in which it operates. We cultivate and maintain strong industry contacts to ensure that we are informed of all pending changes in government and regulatory policy, and we regard our relationships with speakers, delegates and subscribers as an investment for the future.